Post by Apellis Pharmaceuticals

We’re proud to join the community of researchers, clinicians and medical educators committed to child and adolescent health at the Pediatric Academic Societies Meeting this weekend.   To learn how we’re leveraging complement-driven science across a broad range of serious diseases, including conditions that affect pediatric patients like C3G and primary IC-MPGN, visit #TeamApellis at booth #219! #WeAreApellis #PAS2026